Silo Pharma, Inc. SEC filings SILO
Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 14, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 2, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 19, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Aug 17, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Aug 6, 2026 | — |
| 424B3 | Prospectus | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Jul 31, 2026 | — |
| S-3 | Shelf registration | Jul 24, 2026 | — |
| D | Filing | Jul 14, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 13, 2026 | Jul 9, 2026 |
| ARS | Annual report to shareholders | Jun 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jun 30, 2026 | — |
| DEF 14A | Proxy statement | Jun 30, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Jun 18, 2026 | Jun 17, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 18, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 3, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 424B3 | Prospectus | Apr 16, 2026 | — |
| EFFECT | Filing | Apr 15, 2026 | — |
| 424B3 | Prospectus | Apr 14, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 14, 2026 | — |
| EFFECT | Filing | Apr 13, 2026 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Apr 10, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 2, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 23, 2026 | Feb 20, 2026 |
| 8-K |
Current report
Listing notice
|
Dec 29, 2025 | Dec 24, 2025 |
| EFFECT | Filing | Nov 26, 2025 | — |
| 424B3 | Prospectus | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| S-1 | Registration statement | Oct 29, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 1, 2025 | Sep 29, 2025 |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| DEFA14A | Additional proxy material | Sep 5, 2025 | — |
| ARS | Annual report to shareholders | Sep 5, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Sep 5, 2025 | Oct 24, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2025 | Aug 25, 2025 |
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Aug 5, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 10, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
May 16, 2025 | May 15, 2025 |
| 424B4 | Prospectus | May 16, 2025 | — |
| EFFECT | Filing | May 15, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| S-1/A | Amended registration statement | May 9, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| S-1/A | Amended registration statement | Apr 29, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| S-1 | Registration statement | Apr 25, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| DRS | Filing | Apr 11, 2025 | — |
| 424B3 | Prospectus | Apr 4, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| POS AM | Post-effective amendment to form s-1 | Mar 28, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Other events
|
Mar 7, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Other events
|
Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2024 | Dec 20, 2024 |
| DEFR14A | Proxy statement | Nov 15, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 8, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 8, 2024 | Nov 8, 2024 |
| ARS | Annual report to shareholders | Sep 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Sep 18, 2024 | — |
| DEF 14A | Proxy statement | Sep 18, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 424B3 | Prospectus | Sep 4, 2024 | — |
| EFFECT | Filing | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| S-1 | Registration statement | Aug 21, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| D | Filing | Aug 2, 2024 | — |
| 424B3 | Prospectus | Jul 31, 2024 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| S-1/A | Amended registration statement | Jul 25, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 22, 2024 | Jul 18, 2024 |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| S-1 | Registration statement | Jul 17, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 8, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 27, 2024 | Jun 26, 2024 |
| D | Filing | Jun 11, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 6, 2024 | Jun 4, 2024 |
| 424B5 | Prospectus supplement | Jun 6, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 4, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 4, 2024 |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Feb 1, 2024 | Feb 1, 2024 |
| EFFECT | Filing | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| S-3/A | Amendment no. 1 to form s-3 | Jan 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2024 | — |
| S-3 | Shelf registration | Jan 23, 2024 | — |
| 8-K/A |
Amended current report
Other events
|
Jan 11, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Other events
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K12B | Current report | Dec 20, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Dec 5, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 14, 2023 | Nov 10, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Oct 23, 2023 | — |
| DEF 14A | Proxy statement | Oct 23, 2023 | Dec 4, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Other events
|
Aug 31, 2023 | Aug 25, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Jun 29, 2023 | Jun 28, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 27, 2023 | Mar 27, 2023 |
| 10-K | Annual report | Mar 24, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Feb 15, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Other events
|
Feb 3, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Other events
|
Jan 31, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 20, 2023 | Jan 15, 2023 |
| 8-K |
Current report
Other events
|
Dec 1, 2022 | Dec 1, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
|
Oct 18, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Sep 30, 2022 | Sep 26, 2022 |
| 424B4 | Prospectus | Sep 28, 2022 | — |
| CERT | 8a cert | Sep 27, 2022 | — |
| EFFECT | Filing | Sep 26, 2022 | — |
| 8-A12B | For registration of certain classes | Sep 26, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| S-1/A | Amended registration statement | Sep 20, 2022 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 15, 2022 | Sep 14, 2022 |
| S-1/A | Amended registration statement | Sep 9, 2022 | — |
| S-1/A | Amended registration statement | Aug 29, 2022 | — |
| 10-Q | Quarterly report | Aug 1, 2022 | Jun 30, 2022 |
| S-1/A | Amended registration statement | Jul 25, 2022 | — |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Mar 11, 2022 | Mar 11, 2022 |
| DEFA14A | Additional proxy material | Mar 7, 2022 | — |
| 8-K |
Current report
Other events
|
Mar 7, 2022 | Mar 7, 2022 |
| DEF 14A | Proxy statement | Feb 14, 2022 | Mar 11, 2022 |
| PRE 14A | Preliminary proxy statement | Feb 2, 2022 | Feb 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 4, 2022 | Dec 29, 2021 |
| UPLOAD | Letter from the SEC | Dec 15, 2021 | — |
| S-1 | Registration statement | Dec 7, 2021 | — |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement
|
Oct 27, 2021 | Oct 1, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Other events
|
Aug 18, 2021 | Aug 17, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 12, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 7, 2021 | Jun 1, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-K/A | Amended annual report | May 17, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 28, 2021 | Apr 22, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 16, 2021 | Apr 12, 2021 |
| 424B3 | Prospectus | Apr 13, 2021 | — |
| EFFECT | Filing | Apr 12, 2021 | — |
| CORRESP | Letter to the SEC | Apr 8, 2021 | — |
| S-1/A | Amended registration statement | Apr 7, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 7, 2021 | Apr 6, 2021 |
| 10-K | Annual report | Mar 29, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Mar 12, 2021 | Mar 10, 2021 |
| DEF 14A | Proxy statement | Feb 22, 2021 | Mar 10, 2021 |
| D | Filing | Feb 22, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2021 | — |
| DEFA14A | Additional proxy material | Feb 16, 2021 | — |
| S-1 | Registration statement | Feb 16, 2021 | — |
| 8-K |
Current report
Material agreement
|
Feb 16, 2021 | Feb 12, 2021 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Feb 12, 2021 | Feb 9, 2021 |
| PRE 14A | Preliminary proxy statement | Feb 10, 2021 | Mar 10, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Feb 10, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2021 | Jan 18, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 11, 2021 | Jan 5, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 11, 2021 | Jan 5, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 4, 2020 | Dec 1, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 424B3 | Prospectus | Oct 20, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 20, 2020 | Oct 20, 2020 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Oct 6, 2020 | Sep 24, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 424B3 | Prospectus | Jun 8, 2020 | — |
| EFFECT | Filing | Jun 4, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 29, 2020 | — |
| S-1 | Registration statement | May 22, 2020 | — |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| D | Filing | May 8, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 29, 2020 | Apr 28, 2020 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 22, 2020 | Apr 15, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 21, 2020 | Apr 15, 2020 |
| 10-K | Annual report | Mar 20, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2020 | Jan 16, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SILO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514183
- Former names
- Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.